Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 17, 2025 09:00 ET | Source: NovalGen Ltd.

NovalGen to Begin World’s First Clinical Trial for a Self-Regulating Immunotherapy

Groundbreaking cancer therapy that self-inactivates when there is risk of toxicity approved by MHRA for entry into Phase I clinical trial